Thomas Bieber Selected Research

Anti-Bacterial Agents (Antibiotics)

9/2019	[Facial necrosis caused by orthopoxvirus : Differential diagnosis and dermatohistopathological correlation of infectious facial ulcers].
9/2005	Keratitis-ichthyosis-deafness syndrome in association with follicular occlusion triad.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Bieber Research Topics

Disease

85	Atopic Dermatitis (Atopic Eczema) 05/2024 - 03/2002
31	Inflammation (Inflammations) 10/2023 - 03/2005
16	Eczema 11/2023 - 10/2006
15	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2023 - 03/2005
15	Pruritus (Itching) 09/2023 - 03/2002
14	Neoplasms (Cancer) 12/2023 - 04/2003
13	Cutaneous Lupus Erythematosus 01/2021 - 03/2005
11	Infections 12/2023 - 10/2005
11	Skin Diseases (Skin Disease) 03/2023 - 05/2004
8	Melanoma (Melanoma, Malignant) 01/2020 - 04/2005
8	Hypersensitivity (Allergy) 11/2018 - 07/2004
7	Asthma (Bronchial Asthma) 01/2023 - 07/2007
7	Dermatitis 01/2020 - 10/2002
5	Dysbiosis 11/2023 - 01/2018
5	COVID-19 09/2023 - 01/2020
4	Prurigo 01/2023 - 01/2020
4	Dermatomyositis (Dermatopolymyositis) 01/2023 - 01/2006
4	Nasopharyngitis 01/2022 - 07/2014
4	Autoimmune Diseases (Autoimmune Disease) 01/2016 - 03/2005
3	Rheumatoid Arthritis 10/2023 - 01/2014
3	Headache (Headaches) 01/2022 - 07/2014
3	Neoplasm Metastasis (Metastasis) 01/2020 - 04/2005
3	Virus Diseases (Viral Diseases) 05/2010 - 08/2005
3	Lichen Planus (Lichen Ruber Planus) 12/2007 - 03/2005
2	Conjunctivitis 11/2023 - 12/2016
2	Eosinophilia 01/2023 - 09/2004
2	Venous Thromboembolism 01/2023 - 11/2022
2	Chronic Urticaria 01/2023 - 07/2011
2	Herpes Simplex 11/2022 - 01/2022
2	Herpes Zoster 11/2022 - 06/2019
2	Bullous Pemphigoid (Pemphigoid) 03/2022 - 03/2005
2	Injection Site Reaction 08/2021 - 12/2016
2	Disease Progression 04/2021 - 04/2015
2	Acne Vulgaris 01/2021 - 01/2021
2	Discoid Lupus Erythematosus 01/2021 - 01/2002
2	Erythema 12/2020 - 07/2005
2	Kaposi Varicelliform Eruption (Eczema Herpeticum) 06/2019 - 07/2008
2	Spontaneous Remission 11/2018 - 07/2005

Drug/Important Bio-Agent (IBA)

17	Immunoglobulin E (IgE)IBA 12/2023 - 10/2002
16	Interleukin-13IBA 11/2023 - 10/2002
16	CytokinesIBA 11/2023 - 10/2002
13	dupilumabIBA 01/2023 - 07/2014
11	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2023 - 03/2002
10	Monoclonal AntibodiesIBA 10/2023 - 01/2006
10	AllergensIBA 11/2018 - 05/2008
9	baricitinibIBA 12/2023 - 12/2020
9	InterleukinsIBA 11/2023 - 10/2005
9	Interleukin-4 (Interleukin 4)IBA 01/2022 - 10/2002
8	Biomarkers (Surrogate Marker)IBA 04/2024 - 07/2014
8	LigandsIBA 10/2023 - 06/2005
8	Interferon Type IIBA 08/2021 - 03/2005
7	Janus KinasesIBA 12/2023 - 09/2017
7	Proteins (Proteins, Gene)FDA Link 10/2017 - 04/2005
6	Janus Kinase InhibitorsIBA 10/2023 - 01/2017
6	abrocitinibIBA 01/2023 - 01/2020
6	Tacrolimus (Prograf)FDA LinkGeneric 03/2009 - 03/2002
5	Immunoglobulin A (IgA)IBA 11/2023 - 09/2020
5	Immunosuppressive Agents (Immunosuppressants)IBA 01/2023 - 01/2005
5	AntigensIBA 10/2020 - 11/2003
5	ruxolitinibIBA 05/2020 - 12/2014
5	Antiviral Agents (Antivirals)IBA 09/2019 - 07/2005
5	pimecrolimus (Elidel)FDA Link 02/2011 - 03/2005
5	Chemokine ReceptorsIBA 10/2009 - 03/2005
5	ChemokinesIBA 10/2009 - 10/2002
4	Janus Kinase 1IBA 12/2023 - 01/2020
4	Imiquimod (Aldara)FDA LinkGeneric 04/2021 - 01/2002
4	EnzymesIBA 02/2012 - 09/2004
3	omega-Chloroacetophenone (Mace)IBA 12/2023 - 11/2022
3	tralokinumabIBA 11/2023 - 10/2021
3	lebrikizumabIBA 09/2023 - 01/2018
3	upadacitinibIBA 01/2023 - 01/2021
3	VaccinesIBA 01/2022 - 08/2004
3	InterferonsIBA 01/2022 - 12/2008
3	Nucleic AcidsIBA 01/2020 - 11/2007
3	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2016 - 01/2010
3	Calcineurin InhibitorsIBA 07/2014 - 03/2005
3	Interferon-alpha (Interferon Alfa)IBA 11/2012 - 01/2006
3	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 02/2012 - 12/2007
3	Ointments (Pastes)IBA 01/2007 - 03/2002
2	Peptides (Polypeptides)IBA 12/2023 - 10/2005
2	AutoantibodiesIBA 12/2023 - 07/2011
2	AntibodiesIBA 12/2023 - 07/2011
2	Methotrexate (Mexate)FDA LinkGeneric 11/2023 - 01/2014
2	AutoantigensIBA 01/2023 - 07/2011
2	nemolizumabIBA 01/2023 - 01/2020
2	Immune Checkpoint InhibitorsIBA 03/2022 - 01/2020
2	BNT162 VaccineIBA 01/2022 - 01/2021
2	mRNA VaccinesIBA 01/2022 - 01/2021
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022 - 03/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 09/2019 - 09/2005
2	Immunologic Factors (Immunomodulators)IBA 06/2019 - 01/2003
2	Interleukin-17 (Interleukin 17)IBA 07/2018 - 04/2015
2	Filaggrin ProteinsIBA 01/2018 - 09/2008
2	Histamine (Histamine Dihydrochloride)FDA Link 09/2017 - 09/2008

Therapy/Procedure

31	Therapeutics 05/2024 - 05/2005
9	Immunotherapy 05/2024 - 04/2003
4	Precision Medicine 01/2023 - 01/2016
2	Contraindications 01/2022 - 03/2009
2	Lasers (Laser) 01/2021 - 03/2011
2	Injections 01/2020 - 05/2010